| Symbol | GCTK |
|---|---|
| Name | GLUCOTRACK, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 301 RTE. 17 NORTH,,STE. 800, RUTHERFORD, New Jersey, 07070, United States |
| Telephone | +201 842 7715 |
| Fax | — |
| — | |
| Website | https://www.glucotrack.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001506983 |
| Description | GlucoTrack Inc, former Integrity Applications, Inc. is a medical device company. The Company is focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by persons suffering from diabetes. It has developed a non-invasive blood glucose monitor, the GlucoTrack Model DF-F glucose monitoring device, which is designed to help people with diabetes obtain blood glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot finger stick devices. The Company operates in Europe, and Asia and Pacific. The GlucoTrack model DF-F utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain blood glucose measurements in less than one minute through a small sensor that is clipped onto ones earlobe and connected to a small, handheld control and display unit, all without drawing blood. Additional info from NASDAQ: |
New Form DEF 14A - Glucotrack, Inc. <b>Filed:</b> 2026-08-10 <b>AccNo:</b> 0001493152-26-036870 <b>Size:</b> 958 KB
Read moreCORRECTING and REPLACING Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline
Read moreNew Form PRE 14A - Glucotrack, Inc. <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001493152-26-035648 <b>Size:</b> 1 MB
Read moreLōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline
Read more(99% Neutral) GLUCOTRACK, INC. (GCTK) Announces Enrollment Update for preparing Due to Patient Enrollment Issues, Regulatory Process
Read moreLōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
Read moreNew Form 8-K/A - Glucotrack, Inc. <b>Filed:</b> 2026-07-29 <b>AccNo:</b> 0001493152-26-035242 <b>Size:</b> 279 KB <br />Item 1.01: Entry into a Material Definitive Agreement <br />Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Reg…
Read more